Metahelix Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 28.81 Cr
- Paid Up Capital ₹ 1.08 M
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 122.45 Cr
- Revenue Growth 5.49%
- Profit Growth -5.47%
- Ebitda -16.53%
- Net Worth 20.14%
- Total Assets 15.88%
About Metahelix Life Sciences
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KA2000PLC028246
-
Company No.
028246
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
11 Dec 2000
-
Date of AGM
24 Jun 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Metahelix Life Sciences Limited offer?
Metahelix Life Sciences Limited offers a wide range of products and services, including Yarns & Threads, Cotton, Pharma & Bioanalytical Services, Pharmaceutical Services, Machines & Equipments, Industrial Oil Filter Machine, Seeds and Plant Saplings, Grain Seed, Research and Development (R&D) Work, Product Development Research.
Who are the key members and board of directors at Metahelix Life Sciences?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Suresh Kannan | CFO | 01-Apr-2014 | Current |
Hurukadli Virupakshappa | Company Secretary | 01-Apr-2019 | Current |
Kannan Suresh | CFO | 01-Apr-2014 | Current |
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Punita Sinha | Director | 01-Apr-2015 | Current |
Ramakrishnan Mukundan | Director | 30-Dec-2010 | Current |
Collur Natraj | Director | 01-Apr-2015 | Current |
Ashish Mehta | Director | 01-Apr-2019 | Current |
Nagarajan Swaminathan | Director | 01-Apr-2016 | Current |
Sanjiv Lal | Additional Director | 13-Jul-2019 | Current |
Financial Performance of Metahelix Life Sciences.
Metahelix Life Sciences Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 5.49% increase. The company also saw a slight decrease in profitability, with a 5.47% decrease in profit. The company's net worth Soared by an impressive increase of 20.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Metahelix Life Sciences?
In 2019, Metahelix Life Sciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹122.45 Cr
Charges Breakdown by Lending Institutions
- Kotak Mahindra Bank Limited : 45.20 Cr
- Hdfc Bank Limited : 31.00 Cr
- Union Bank Of India : 26.25 Cr
- Yes Bank Limited : 20.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Mar 2013 | Yes Bank Limited | ₹20.00 Cr | Satisfied |
20 Apr 2012 | Hdfc Bank Limited | ₹26.00 Cr | Satisfied |
09 Apr 2012 | Kotak Mahindra Bank Limited | ₹1.60 Cr | Satisfied |
09 Dec 2011 | Kotak Mahindra Bank Limited | ₹2.00 Cr | Satisfied |
01 Jul 2011 | Kotak Mahindra Bank Limited | ₹41.60 Cr | Satisfied |
How Many Employees Work at Metahelix Life Sciences?
Unlock and access historical data on people associated with Metahelix Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metahelix Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metahelix Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.